Page last updated: 2024-10-23

bethanechol and Dystonia

bethanechol has been researched along with Dystonia in 1 studies

Bethanechol: A slowly hydrolyzing muscarinic agonist with no nicotinic effects. Bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, HEART RATE changes, and BRONCHIAL SPASM.
bethanechol : The carbamic acid ester of 2-methylcholine. A slowly hydrolysed muscarinic agonist with no nicotinic effects, it is used as its chloride salt to increase smooth muscle tone, as in the gastrointestinal tract following abdominal surgery, treatment of gastro-oesophageal reflux disease, and as an alternative to catheterisation in the treatment of non-obstructive urinary retention.

Dystonia: An attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often affects the large axial muscles of the trunk and limb girdles. Conditions which feature persistent or recurrent episodes of dystonia as a primary manifestation of disease are referred to as DYSTONIC DISORDERS. (Adams et al., Principles of Neurology, 6th ed, p77)

Research Excerpts

ExcerptRelevanceReference
"Bethanechol is a direct agonist of the acetylcholine receptor that was recently introduced in the therapy of gastro-oesophageal reflux."3.67Acute dystonic reaction to bethanechol--a direct acetylcholine receptor agonist. ( Beharab, A; Levy, Y; Nitzam, M; Shafrir, Y; Steinherz, R, 1986)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shafrir, Y1
Levy, Y1
Beharab, A1
Nitzam, M1
Steinherz, R1

Other Studies

1 other study available for bethanechol and Dystonia

ArticleYear
Acute dystonic reaction to bethanechol--a direct acetylcholine receptor agonist.
    Developmental medicine and child neurology, 1986, Volume: 28, Issue:5

    Topics: Acute Disease; Bethanechol; Bethanechol Compounds; Dystonia; Gastroesophageal Reflux; Humans; Infant

1986